- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT01799031
Educational Intervention for Reducing Work Disability in Breast Cancer Survivors
Reducing Work Disability in Breast Cancer Survivors
Studie Overzicht
Toestand
Conditie
Gedetailleerde beschrijving
PRIMARY OBJECTIVES:
I. Determine the feasibility and usability of the Work Ability Improvement Through Symptom Management and Ergonomic Strategies (WISE) and empirically evaluate its effect on short-term work ability among breast cancer survivors (BCS).
SECONDARY OBJECTIVES:
I. Explore individual and workplace factors associated with work ability in BCS.
OUTLINE: Patients are randomized to 1 of 2 treatment arms.
ARM I: Patients receive access to the WISE web-based educational intervention to help BCS manage their symptoms, identify ergonomic workplace problems and risks, and implement ergonomic modifications. Patients also receive standard of care comprising symptom management therapies and a pamphlet on employment rights.
ARM II: Patients receive standard of care comprising symptom management therapies and a pamphlet on employment rights.
After completion of study treatment, patients are followed up at 3 and 6 months.
Studietype
Inschrijving (Werkelijk)
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
Wisconsin
-
Madison, Wisconsin, Verenigde Staten, 53792
- University of Wisconsin Hospital and Clinics
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- Diagnosed with breast cancer
- Employed at time of cancer diagnosis (defined as paid employment > 20 hours/week)
- Within six months of completion of active treatment
- Working during treatment or intending to return to work following active treatment
- Computer and internet access
Exclusion Criteria:
- Patients who do not intend to continue/resume working following treatment
- Develop distant metastases or progressive disease
- Prior diagnosis of malignancy at any other site except for in situ carcinomas of the cervix or non-melanomatous skin cancers
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Ondersteunende zorg
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Arm I (WISE)
Patients receive access to the WISE web-based educational intervention to help BCS manage their symptoms, identify ergonomic workplace problems and risks, and implement ergonomic modifications.
Patients also receive standard of care comprising symptom management therapies and a pamphlet on employment rights.
|
Nevenstudies
Nevenstudies
Andere namen:
Receive access to the WISE web-based educational intervention
Receive standard of care
Andere namen:
Receive access to the WISE web-based educational intervention
Andere namen:
|
|
Actieve vergelijker: Arm II (control)
Patients receive standard of care comprising symptom management therapies and a pamphlet on employment rights.
|
Nevenstudies
Nevenstudies
Andere namen:
Receive standard of care
Andere namen:
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Usability of the WISE website as assessed by responses to a 5-point Likert scale
Tijdsspanne: 3 months
|
The primary analysis of the effect of the WISE intervention on work ability will be performed using a Wilcoxon rank sum test.
|
3 months
|
|
Usability of the WISE website as assessed by responses to a 5-point Likert scale
Tijdsspanne: 6 months
|
The primary analysis of the effect of the WISE intervention on work ability will be performed using a Wilcoxon rank sum test.
|
6 months
|
|
Work ability, assessed by the Work Limitations Questionnaire (WLQ)
Tijdsspanne: Baseline
|
Baseline
|
|
|
Work ability, assessed by the WLQ
Tijdsspanne: 3 months
|
3 months
|
|
|
Work ability, assessed by the WLQ
Tijdsspanne: 6 months
|
6 months
|
|
|
Individual factors, including symptoms assessed using the Symptom Bother-Revised scale (SB-R) and MD Anderson Symptom Inventory (MDASI), socio-demographic factors, individual disease factors, and treatment factors
Tijdsspanne: Baseline
|
Baseline
|
|
|
Individual factors, including symptoms assessed using the SB-R and MDASI, socio-demographic factors, individual disease factors, and treatment factors
Tijdsspanne: 3 months
|
3 months
|
|
|
Individual factors, including symptoms assessed using the SB-R and MDASI, socio-demographic factors, individual disease factors, and treatment factors
Tijdsspanne: 6 months
|
6 months
|
|
|
Workplace factors, including work history, job characteristics, job control, job support, and level of job stress using the Job Content Questionnaire (JCQ)
Tijdsspanne: Baseline
|
Baseline
|
|
|
Workplace factors, including work history, job characteristics, job control, job support, and level of job stress using the JCQ
Tijdsspanne: 3 months
|
3 months
|
|
|
Workplace factors, including work history, job characteristics, job control, job support, and level of job stress using the JCQ
Tijdsspanne: 6 months
|
6 months
|
Secundaire uitkomstmaten
Uitkomstmaat |
Tijdsspanne |
|---|---|
|
Feasibility measures, including participation/dropout rates, patient satisfaction, usability/satisfaction with WISE, knowledge/use of self-care symptom management/ergonomic strategies, and use of ergonomic/symptom management strategies, and barriers
Tijdsspanne: Up to 6 months
|
Up to 6 months
|
|
Self-car symptom management strategies used (if any), workplace strategies implemented, and barriers to implementation
Tijdsspanne: Up to 6 months
|
Up to 6 months
|
|
Individuals self-reported work ability, using the Work Ability Index (WAI)
Tijdsspanne: Up to 6 months
|
Up to 6 months
|
|
Employment status
Tijdsspanne: Up to 6 months
|
Up to 6 months
|
|
Change in job performance or difficulty performing work tasks
Tijdsspanne: Baseline to 6 months
|
Baseline to 6 months
|
Medewerkers en onderzoekers
Sponsor
Medewerkers
Onderzoekers
- Hoofdonderzoeker: Mary Sesto, University of Wisconsin, Madison
Publicaties en nuttige links
Nuttige links
Studie record data
Bestudeer belangrijke data
Studie start
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Schatting)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- OS12115
- A536130 (Andere identificatie: UW Madison)
- NCI-2012-03055 (Register-ID: NCI Trial ID)
- 2012-0729 (Andere identificatie: Institutional Review Board)
- SMPH\ORTHOPEDIC&REHAB\PT (Andere identificatie: UW Madison)
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .
Klinische onderzoeken op Borstkanker
-
Xijing HospitalActief, niet wervendBorstkanker | Borstkanker (Triple Negative Breast Cancer (TNBC))China
-
Shanghai Henlius BiotechNog niet aan het wervenBorstkanker (Triple Negative Breast Cancer (TNBC))China
-
BioNTech SESeventh Framework ProgrammeVoltooidBorstkanker (Triple Negative Breast Cancer (TNBC))Zweden, Duitsland
-
Novartis PharmaceuticalsVoltooidGeavanceerde Triple Negative Breast Cancer (TNBC) met hoge TAM'sFrankrijk, Italië, Oostenrijk, Taiwan, Verenigde Staten, Spanje, Australië, Korea, republiek van, België, Duitsland, Hongkong, Kalkoen
-
Tianjin Medical University Cancer Institute and...Guangxi Medical University; Sun Yat-sen University; Chinese PLA General Hospital; The First Affiliated Hospital of Zhengzhou University en andere medewerkersVoltooidDe klinische toepassingsgids van Conebeam Breast CTChina
-
Sun Yat-sen UniversityNog niet aan het wervenCancer therapie-geïnduceerde trombocytopenie (CTIT)
-
OHSU Knight Cancer InstituteOregon Health and Science UniversityActief, niet wervendPancreas Adenocarcinoom | Fase III Pancreaskanker American Joint Committee on Cancer v8 | Stadium 0 Pancreaskanker American Joint Committee on Cancer v8 | Stadium I alvleesklierkanker American Joint Committee on Cancer v8 | Stadium IV alvleesklierkanker American Joint Committee on Cancer...Verenigde Staten
-
Centre Hospitalier Universitaire, AmiensVoltooidEnt Cancer ScreeningFrankrijk
-
Hitit UniversityErol Olcok Corum Training and Research HospitalVoltooidHysterectomie (MeSH nr: E04.950.300.399) | Had een hysterectomie ondergaan | Had Not Been Diagnosed With Cancer | Na hysterectomieTurkije (Türkiye)
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)VoltooidAdenocarcinoom van de dunne darm | Stadium III Adenocarcinoom van de dunne darm AJCC v8 | Stadium IIIA Adenocarcinoom van de dunne darm AJCC v8 | Stadium IIIB dunne darm adenocarcinoom AJCC v8 | Stadium IV Adenocarcinoom van de dunne darm AJCC v8 | Ampulla van Vater Adenocarcinoom | Stadium III... en andere voorwaardenVerenigde Staten
Klinische onderzoeken op vragenlijst administratie
-
Virginia Commonwealth UniversityRigel PharmaceuticalsWervingAcute myeloïde leukemieVerenigde Staten
-
Tang-Du HospitalNog niet aan het werven
-
University of CalgaryNog niet aan het wervenCoronaire hartziekte | Hartfalen | Diabetes mellitus | Chronische longziekten | NierziekteCanada
-
The First Hospital of QinhuangdaoVoltooidKruis infectie | Interdisciplinaire communicatie | Verpleegkundige zorg | Patiëntenzorgbundels | Apparatuur en benodigdheden | Intensive Care Units (ICU's)China
-
Toros UniversityNog niet aan het wervenMetaboolsyndroom | Obesitas, morbide | Darmpermeabiliteit | Bariatrische Chirurgie | Gastro-intestinale symptomenTurkije (Türkiye)
-
Istanbul University - CerrahpasaWerving
-
University of SunderlandUniversity of GlasgowNog niet aan het wervenProstaatkanker (diagnose)
-
University of Texas Southwestern Medical CenterWervingHypertensie | Type 2 diabetesVerenigde Staten
-
University of New MexicoActief, niet wervendKindermishandeling | Ouderschap | Gedrag van het kind | Kinder ontwikkeling | Achterstalligheid | Crimineel gedrag | Verwaarlozing van kinderenVerenigde Staten
-
University of ChicagoNorthwestern University; University of Illinois at Chicago; Rush University Medical... en andere medewerkersActief, niet wervendMedicare-patiënten | Hoog risico op ziekenhuisopnamesVerenigde Staten